Literature DB >> 8358998

Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis.

R Omdal, L Gøransson, H Bergrem.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358998     DOI: 10.1007/bf02231548

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

1.  Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia.

Authors:  A Kraus; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

2.  Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment.

Authors:  M Maricic; M Davis; E P Gall
Journal:  Arthritis Rheum       Date:  1986-01

3.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

Review 4.  Long-term methotrexate therapy for rheumatoid arthritis.

Authors:  C J Scully; C J Anderson; G W Cannon
Journal:  Semin Arthritis Rheum       Date:  1991-04       Impact factor: 5.532

5.  Severe pancytopenia in a patient taking low dose methotrexate and probenecid.

Authors:  K S Basin; A Escalante; T D Beardmore
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

6.  Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis.

Authors:  S G Kevat; W R Hill; P J McCarthy; M J Ahern
Journal:  Aust N Z J Med       Date:  1988-08

7.  Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis.

Authors:  S K MacKinnon; G Starkebaum; R F Willkens
Journal:  Semin Arthritis Rheum       Date:  1985-11       Impact factor: 5.532

8.  Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding.

Authors:  J R Taylor; K M Halprin
Journal:  Arch Dermatol       Date:  1977-05
  8 in total
  2 in total

1.  Low dose methotrexate and bone marrow suppression.

Authors:  Michael Sosin; Sunil Handa
Journal:  BMJ       Date:  2003-02-01

2.  Clinical characteristics related to methotrexate-induced pancytopenia.

Authors:  Y Ohosone; Y Okano; H Kameda; N Hama; T Mimori; M Akizuki; Y Ikeda
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.